AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8329880
Drug: Conjoint therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint therapy component in social-learning-based alcoholism treatment
Trial: 8329880
Drug: Social-learning-based alcoholism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social-learning-based alcoholism treatment without conjoint therapy
Trial: 8329880
Drug: Conjoint treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint treatment with high-autonomy alcoholics
Trial: 8329880
Drug: Treatment without
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment without other family members for low-autonomy alcoholics
Trial: 3525077
Drug: Busulfan (4-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Busulfan (4-6 mg/day during 4-8 weeks, with re-administration at relapse)
Trial: 22456602
Drug: Six times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six times per week hemodialysis (Daily Trial)
Trial: 22456602
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times per week hemodialysis (Daily Trial)
Trial: 15826611
Drug: Clarified appearance
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarified appearance question (e.g., 'What does the sponge look like?')
Trial: 8875683
Drug: Furosemide (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (15 mg/kg)
Trial: 6203596
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dextran 70 and dihydroergotamine (DHE)
Trial: 31579904
Drug: empagliflozin 10
RxNorm normalized name: empagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: empagliflozin 10 or 25 mg
Trial: 24646104
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg sc every 6 months (n = 500)
Trial: 24646104
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate 35 mg weekly (n = 251)
Trial: 20222915
Drug: lesogaberan (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lesogaberan (0.8 mg/kg)
Trial: 20222915
Drug: baclofen (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: baclofen (40 mg)
Trial: 18019850
Drug: d‐threo‐methylphenidate (d‐MPH)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d‐threo‐methylphenidate (d‐MPH) 5‐15 mg twice daily
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g SPP
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g SPP (raw)
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g SPP (baked into bread)
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g oat bran
Trial: 9505155
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g wheat bran
Trial: 9505155
Drug: 180 g
RxNorm normalized name: GLYCERIN 9 mg in 180 g / PANTHENOL 7 mg in 180 g CUTANEOUS FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 g wheat flour (control bread)
Trial: 9505155
Drug: 180 g
RxNorm normalized name: GLYCERIN 9 mg in 180 g / PANTHENOL 7 mg in 180 g CUTANEOUS FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 g wheat flour with 20 g raw SPP (bread)
Trial: 9505155
Drug: 180 g
RxNorm normalized name: GLYCERIN 9 mg in 180 g / PANTHENOL 7 mg in 180 g CUTANEOUS FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 g wheat flour with 20 g SPP (baked bread)
Trial: 2507265
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin plus 10 mg glyburide
Trial: 799563
Drug: Timolol alone
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol alone (10 mg)
Trial: 799563
Drug: Hydrochlorothiazide +
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide + amiloride (25 mg + 2-5 mg)
Trial: 799563
Drug: Timolol +
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol + hydrochlorothiazide + amiloride (10 mg + 25 mg + 2-5 mg)
Trial: 21054800
Drug: Topical misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical misoprostol (100 µg)
Trial: 17853018
Drug: Bilateral periprostatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral periprostatic infiltration of 5 cm(3) of 0.9% saline solution
Trial: 2896828
Drug: Edmonston-Zagreb (E-Z)
RxNorm normalized name: measles virus vaccine live, Enders' attenuated Edmonston strain / mumps virus vaccine live, Jeryl Lynn strain / rubella virus vaccine live (Wistar RA 27-3 strain) / varicella-zoster virus vaccine live (Oka-Merck) strain Injection [ProQuad]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edmonston-Zagreb (E-Z) measles vaccine, 40,000 plaque forming units
Trial: 2896828
Drug: Schwarz vaccine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schwarz vaccine, 40,000 plaque forming units
Trial: 28402415
Drug: Single-dose misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose misoprostol (800 μg vaginally on Day 1)
Trial: 28402415
Drug: Repeat-dose misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repeat-dose misoprostol (800 μg vaginally on Day 1, with a second dose if required on Day 4)
Trial: 28402415
Drug: Repeat-dose misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repeat-dose misoprostol
Trial: 26185033
Drug: BMP-2/H (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMP-2/H (1 mg/mL of rhBMP-2 soaked with hydroxyapatite granules, 0.5 to 2.0 g; n = 65)
Trial: 26185033
Drug: ABX (inorganic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABX (inorganic bovine bone xenograft, 0.5 to 2.0 g; n = 62)
Trial: 23295964
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and hepatitis B vaccine (first dose)
Trial: 23295964
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and hepatitis B vaccine (third dose)
Trial: 23295964
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and hepatitis B vaccine (first booster dose)
Trial: 14658976
Drug: Long-acting injectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting injectable risperidone (25 mg, 50 mg, or 75 mg every 2 weeks for 12 months)
Trial: 9179067
Drug: Nonabsorbable antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonabsorbable antibiotic lozenge
Trial: 3530781
Drug: Bucindolol 50
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 50 mg
Trial: 2866786
Drug: Bucindolol 200
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 200 mg
Trial: 19557424
Drug: Cocktail therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocktail therapy (ESWT, HBO, alendronate)
Trial: 19557424
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave treatment (ESWT) alone
Trial: 16042638
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement and behavioral therapies
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25 mg once daily
Trial: 24229823
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.5 mg once daily
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 1.0 mg once daily
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25 mg twice daily
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.5 mg twice daily
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 1.0 mg twice daily
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.25 mg once daily (study C)
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 0.5 mg twice daily (study C)
Trial: 10518846
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) 1.0 mg once daily (study C)
Trial: 8748720
Drug: Topical terbutaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical terbutaline sulfate (1.0 mg)
Trial: 7004292
Drug: Bethanechol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bethanechol (25 mg tablets, four times daily for 4 weeks)
Trial: 7004292
Drug: Placebo (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (four times daily for 4 weeks)
Trial: 31514744
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (fixation) of medial malleolus fractures
Trial: 31514744
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment (non-fixation) of medial malleolus fractures
Trial: 31514744
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment (fixation)
Trial: 31514744
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment (non-fixation)
Trial: 28990241
Drug: Clinically indicated
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinically indicated replacement of peripheral intravenous catheters (PIVC)
Trial: 28990241
Drug: Routine replacement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine replacement of peripheral intravenous catheters (PIVC) every 72-96 hours
Trial: 25381876
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + low-dose metformin
Trial: 19741313
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (25 g/day for 7 days, then 5 g/day for 14 days)
Trial: 19741313
Drug: Placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (50 g/day glucose for 7 days, then 30 g/day glucose for 14 days)
Trial: 17559754
Drug: Tramadol ER
RxNorm normalized name: tramadol Extended Release Oral Capsule
DrugBank: Tramadol (DB00193)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tramadol ER (100 mg, 200 mg, 300 mg, or 400 mg once daily)
Trial: 31221619
Drug: Epacadostat 100
RxNorm normalized name: epacadostat
DrugBank: Epacadostat (DB11717)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epacadostat 100 mg orally twice daily plus pembrolizumab 200 mg intravenously every 3 weeks
Trial: 24130088
Drug: Autologous skeletal
RxNorm normalized name: Spongia officinalis skeleton extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous skeletal myoblast transplantation (ASM-Tx) - low dosage (400 million cells)
Trial: 24130088
Drug: Autologous skeletal
RxNorm normalized name: Spongia officinalis skeleton extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous skeletal myoblast transplantation (ASM-Tx) - high dosage (800 million cells)
Trial: 22241513
Drug: Esomeprazole (2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (2.5-10 mg) once daily for 2 weeks, followed by weight-adjusted doses for 4 weeks.
Trial: 22241513
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 4 weeks after initial treatment.
Trial: 22241513
Drug: Esomeprazole (2.5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (2.5-10 mg) for infants with symptomatic GERD.
Trial: 20090377
Drug: Individualized parenteral
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized parenteral nutrition (IPN)
Trial: 20090377
Drug: Standardized parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized parenteral nutrition (SPN)
Trial: 12731753
Drug: Zanamivir intranasal
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir intranasal spray (6.4 mg)
Trial: 1656040
Drug: Metoprolol (100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (100-200 mg once daily)
Trial: 31577749
Drug: Low-dose misoprostol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose misoprostol combined with mifepristone
Trial: 27411564
Drug: UNIMMAP containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UNIMMAP containing 60 mg/d iron (reference arm)
Trial: 27411564
Drug: UNIMMAP containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UNIMMAP containing 60 mg/d iron based on weekly hepcidin screening
Trial: 27411564
Drug: UNIMMAP containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UNIMMAP containing 30 mg/d iron for 12 weeks
Trial: 22283356
Drug: Mobile phone
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile phone diaries for daily symptom reporting via morning and evening questionnaires.
Trial: 12885800
Drug: Intraperitoneal chromic
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chromic phosphate suspension (32P) therapy (15 mCi)
Trial: 12885800
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further therapy (NFT)
Trial: 10776506
Drug: Detection of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Detection of antiovarian antibody in POF patients
Trial: 8933855
Drug: Atropine premedication
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine premedication (0.01 mg/kg intramuscularly 30 min before procedure)
Trial: 1896817
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole (140 mg/day)
Trial: 1896817
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole (200 mg/day)
Trial: 1896817
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole (both doses)
Trial: 26104223
Drug: Group problem-solving
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group problem-solving therapy
Trial: 7649340
Drug: Astemizole-D (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole-D (10 mg astemizole/240 mg pseudoephedrine)
Trial: 7649340
Drug: Loratadine-D (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine-D (5 mg loratadine/120 mg pseudoephedrine)
Trial: 1067352
Drug: Combined preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined preventive measures including ingestion of fluoridated water (1.0 ppm), topical application of acidulated phosphate fluoride, application of a pit and fissure sealant, early detection of caries, restoration of affected teeth, and dental health education.
Trial: 31964219
Drug: Doxorubicin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin + Black Seed Oil (80 mg/kg/dose, divided into 3 doses for 1 week after each doxorubicin dose)
Trial: 19317823
Drug: Insulin dose
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin dose calculated for 60 g CHO
Trial: 19317823
Drug: 70-g meal
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 70-g meal
Trial: 8020524
Drug: Iomeprol 300
RxNorm normalized name: Iomeprol 300 MG/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iomeprol 300 mgI/ml at 3 ml/s
Trial: 8020524
Drug: Iomeprol 200
RxNorm normalized name: IOMEPROL
DrugBank: Iomeprol (DB11705)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iomeprol 200 mgI/ml at 3 ml/s
Trial: 8020524
Drug: Iomeprol 300
RxNorm normalized name: Iomeprol 300 MG/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iomeprol 300 mgI/ml at 2 ml/s
Trial: 8020524
Drug: Iomeprol 200
RxNorm normalized name: IOMEPROL
DrugBank: Iomeprol (DB11705)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iomeprol 200 mgI/ml at 2 ml/s
Trial: 16822112
Drug: GA referral
RxNorm normalized name: teferrol
DrugBank: Iron polymaltose (DB15763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GA referral plus 8 sessions of individual CB therapy
Trial: 12839616
Drug: Imiquimod cream,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod cream, applied topically three times a week
Trial: 1698137
Drug: Diethylaminoethyl-dextran (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylaminoethyl-dextran (3 g total) taken 30 min before a standard mixed test meal
Trial: 6163165
Drug: Pentoxifylline (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (300 mg to 600 mg orally for 3 months)
Trial: 6163165
Drug: Conventional fibrinolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fibrinolytic agents only (Control)
Trial: 27923158
Drug: 40mg/day atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40mg/day atorvastatin
Trial: 27923158
Drug: Combined 10mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined 10mg/day atorvastatin with 10mg/day ezetimibe
Trial: 24449008
Drug: Group G
RxNorm normalized name: Prostaglandin group G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group G (gradual perturbation)
Trial: 17391225
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of propofol (25 microg/kg per minute) and ketamine (25 microg/kg per minute)
Trial: 17391225
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of propofol (25 microg/kg per minute) and ketamine (12.5 microg/kg per minute)
Trial: 12036167
Drug: Oxycodone 10
RxNorm normalized name: oxycodone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 10 mg/Acetaminophen 1,000 mg
Trial: 10440879
Drug: Intravesical chemotherapy
RxNorm normalized name: Valrubicin Intravesical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical chemotherapy after transurethral resection
Trial: 3135609
Drug: 1.4 g
RxNorm normalized name: MENTHOL 1.4 g in 100 g TOPICAL CREAM [Cetilar]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.4 g of pivampicillin plus 1.0 g of probenecid, taken once a day for five days
Trial: 3135609
Drug: Sulfamethoxazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole (400 mg) and trimethoprim (80 mg), single ten-tablet dose on the first day, two five-tablet doses on the second day, and two three-tablet doses for the next three to five days
Trial: 3135609
Drug: Sulfamethoxazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfamethoxazole (400 mg) and trimethoprim (80 mg), single ten-tablet dose on the first day and two five-tablet doses on the second day
Trial: 26423742
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNSs) 500 kcal/d
Trial: 21942363
Drug: Immediate dental
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate dental implants without any filling material around the implants (Group A)